JP2013525801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525801A5 JP2013525801A5 JP2013508294A JP2013508294A JP2013525801A5 JP 2013525801 A5 JP2013525801 A5 JP 2013525801A5 JP 2013508294 A JP2013508294 A JP 2013508294A JP 2013508294 A JP2013508294 A JP 2013508294A JP 2013525801 A5 JP2013525801 A5 JP 2013525801A5
- Authority
- JP
- Japan
- Prior art keywords
- daltons
- autism
- cellular
- signature
- metabolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32951510P | 2010-04-29 | 2010-04-29 | |
| US61/329,515 | 2010-04-29 | ||
| PCT/US2011/034654 WO2011139914A1 (en) | 2010-04-29 | 2011-04-29 | Metabolic biomarkers of autism |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015189529A Division JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013525801A JP2013525801A (ja) | 2013-06-20 |
| JP2013525801A5 true JP2013525801A5 (enExample) | 2014-05-22 |
| JP6021187B2 JP6021187B2 (ja) | 2016-11-09 |
Family
ID=44533446
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508294A Expired - Fee Related JP6021187B2 (ja) | 2010-04-29 | 2011-04-29 | 自閉症の代謝バイオマーカー |
| JP2015189529A Pending JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015189529A Pending JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9547013B2 (enExample) |
| EP (1) | EP2564194B1 (enExample) |
| JP (2) | JP6021187B2 (enExample) |
| AU (2) | AU2011248464B2 (enExample) |
| CA (1) | CA2797787C (enExample) |
| WO (1) | WO2011139914A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101322695B1 (ko) * | 2010-08-25 | 2013-10-25 | 주식회사 엘지화학 | 케이블형 이차전지 |
| WO2012048152A2 (en) | 2010-10-07 | 2012-04-12 | Mazmanian Sarkis K | Probiotic therapies for autism |
| CN114949001A (zh) * | 2012-08-29 | 2022-08-30 | 加州理工学院 | 孤独症谱系障碍的诊断和治疗 |
| MX2016000293A (es) | 2013-07-09 | 2016-06-21 | Stemina Biomarker Discovery Inc | Biomarcadores del trastrono del espectro autista. |
| WO2015027116A1 (en) * | 2013-08-21 | 2015-02-26 | The Regents Of The University Of California | Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system |
| CN106537145B (zh) * | 2014-04-08 | 2020-08-25 | 麦特博隆股份有限公司 | 用于疾病诊断和健康评估的个体受试者的小分子生物化学特征分析 |
| US9176113B1 (en) * | 2014-04-11 | 2015-11-03 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| US20150294081A1 (en) | 2014-04-11 | 2015-10-15 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| US10124025B2 (en) | 2014-10-30 | 2018-11-13 | California Institute Of Technology | Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders |
| KR20170086492A (ko) | 2014-10-30 | 2017-07-26 | 캘리포니아 인스티튜트 오브 테크놀로지 | 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법 |
| US11282688B2 (en) | 2015-03-06 | 2022-03-22 | Micromass Uk Limited | Spectrometric analysis of microbes |
| EP3570315B1 (en) | 2015-03-06 | 2024-01-31 | Micromass UK Limited | Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples |
| US11289320B2 (en) | 2015-03-06 | 2022-03-29 | Micromass Uk Limited | Tissue analysis by mass spectrometry or ion mobility spectrometry |
| WO2016142674A1 (en) | 2015-03-06 | 2016-09-15 | Micromass Uk Limited | Cell population analysis |
| CA2981085A1 (en) * | 2015-03-06 | 2016-09-15 | Micromass Uk Limited | Spectrometric analysis |
| JP6421742B2 (ja) | 2015-11-27 | 2018-11-14 | 株式会社デンソー | 車両制御装置 |
| WO2017178833A1 (en) | 2016-04-14 | 2017-10-19 | Micromass Uk Limited | Spectrometric analysis of plants |
| US11707493B2 (en) | 2016-05-23 | 2023-07-25 | California Institute Of Technology | Regulate gut microbiota to treat neurodegenerative disorders |
| CN107064340A (zh) * | 2017-03-13 | 2017-08-18 | 瀚盟测试科技（天津）有限公司 | 一种检测茶叶中gaba含量的方法 |
| WO2018213204A1 (en) | 2017-05-15 | 2018-11-22 | Axial Biotherapeutics, Inc. | Inhibitors of microbially induced amyloid |
| GB201802116D0 (en) | 2018-02-09 | 2018-03-28 | Univ Warwick | Methods for diagnosing an autistic spectrum disorder |
| CN109030665A (zh) * | 2018-10-08 | 2018-12-18 | 黑龙江大学 | 亲水性液相色谱串联质谱法测定红甜菜中甜菜碱含量的检测方法 |
| US12474327B2 (en) | 2018-11-06 | 2025-11-18 | Stalicla Sa | Metabolic profiling for the diagnosis of a subset of idiopathic autism spectrum disorder patients, ADS Phenotype 1 |
| EP4012414A1 (en) | 2020-12-11 | 2022-06-15 | Stalicla S.A. | Diagnosis of autism spectrum disorder phenotype 1 |
| CN113960200B (zh) * | 2021-10-19 | 2023-06-20 | 首都医科大学附属北京儿童医院 | 代谢标志物在诊断儿童adhd合并抽动障碍中的应用 |
| CN114705775B (zh) * | 2022-03-31 | 2023-09-12 | 广东省结核病控制中心 | 一种肺结核评价的血清代谢标志物及其应用 |
| CN115326953A (zh) * | 2022-08-02 | 2022-11-11 | 云谱康(大连)生物科技有限公司 | 一种代谢物组合及应用和检测试剂盒与使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686311A (en) * | 1995-06-23 | 1997-11-11 | The Children's Mercy Hospital | Diagnosis of autism and treatment therefor |
| CA2273683A1 (en) * | 1998-06-15 | 1999-12-15 | Ortho-Clinical Diagnostics, Inc. | Diagnostic markers for human disorders |
| JP2006526140A (ja) | 2002-12-24 | 2006-11-16 | バイオサイト インコーポレイテッド | 鑑別診断のためのマーカーおよびその使用方法 |
| GB0504096D0 (en) | 2005-02-28 | 2005-04-06 | Tipogen As | Method |
| WO2006121952A2 (en) | 2005-05-05 | 2006-11-16 | The Regents Of The University Of California | Diagnostic biomarkers for neurodevelopmental disorders |
| JP5421767B2 (ja) * | 2006-04-10 | 2014-02-19 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | ヒト胚性幹細胞を使用して薬学的化合物および他の化学物質の毒性を評価するための試薬および方法 |
| US8670941B2 (en) * | 2006-08-18 | 2014-03-11 | Huntington Medical Research Institutes | Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease |
| AU2008280806B2 (en) * | 2007-07-26 | 2014-12-11 | Phenomenome Discoveries Inc. | Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders |
| JP5680964B2 (ja) * | 2007-10-04 | 2015-03-04 | ザ ホスピタル フォー シック チルドレン | 自閉症スペクトラム障害のためのバイオマーカー |
| EP2279417B1 (en) * | 2008-05-28 | 2016-07-20 | Georgia Tech Research Corporation | Metabolic biomarkers for ovarian cancer and methods of use thereof |
-
2011
- 2011-04-29 WO PCT/US2011/034654 patent/WO2011139914A1/en not_active Ceased
- 2011-04-29 CA CA2797787A patent/CA2797787C/en active Active
- 2011-04-29 US US13/098,249 patent/US9547013B2/en active Active
- 2011-04-29 EP EP11721395.9A patent/EP2564194B1/en active Active
- 2011-04-29 JP JP2013508294A patent/JP6021187B2/ja not_active Expired - Fee Related
- 2011-04-29 AU AU2011248464A patent/AU2011248464B2/en active Active
-
2015
- 2015-09-28 JP JP2015189529A patent/JP2015231392A/ja active Pending
-
2016
- 2016-07-15 AU AU2016204969A patent/AU2016204969B2/en active Active
- 2016-12-07 US US15/371,692 patent/US10330688B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2797787A1 (en) | Metabolic biomarkers of autism | |
| Wang et al. | Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression | |
| Shao et al. | Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease | |
| Zhu et al. | Single-neuron identification of chemical constituents, physiological changes, and metabolism using mass spectrometry | |
| Uřinovská et al. | Liquid chromatography–tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum | |
| EP3019624B1 (en) | Biomarkers of autism spectrum disorder | |
| Zhou et al. | Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation: J. Zhou et al. | |
| Puchades-Carrasco et al. | Metabolomics in pharmaceutical research and development | |
| Saheb Sharif-Askari et al. | Saliva metabolomic profile of COVID-19 patients associates with disease severity | |
| JP2009528517A5 (enExample) | ||
| JP2019035767A (ja) | 乳癌検出用唾液バイオマーカー、及び、これを用いた乳癌患者を健常者から識別する方法 | |
| CN105738626B (zh) | 一种新的血清代谢物的组合及其作为肝癌诊断标志物的用途 | |
| WO2017082103A1 (ja) | うつ病診断用バイオマーカー及びその使用 | |
| Laila et al. | Role of proteomics in the discovery of autism biomarkers | |
| Zhao et al. | Saliva metabolomics: A non-invasive frontier for diagnosing and managing oral diseases | |
| Quintero et al. | Metabolomic biomarkers in mental disorders: bipolar disorder and schizophrenia | |
| Quanico et al. | Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers | |
| EP2927691B1 (en) | Biomarkers for assessing HIV | |
| CN116678974A (zh) | 一种阿尔茨海默症血浆代谢标志物的筛选方法、血浆代谢标志物及应用 | |
| WO2018191866A1 (zh) | 2型糖尿病标志物及其用途 | |
| Li et al. | Dysregulation of glutamine/glutamate metabolism in COVID‐19 patients: A metabolism study in African population and mini meta‐analysis | |
| Bonomo et al. | Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting | |
| WO2015168426A1 (en) | Metabolic and genetic biomarkers for memory loss | |
| CN112305121A (zh) | 代谢标志物在动脉粥样硬化性脑梗死中的应用 | |
| Liu et al. | Human Umbilical Cord Plasma Metabolomics Uncover Potential Metabolites for Combating Aging |